Trade IMNN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Imunon, Inc. (IMNN) is trading at US$1.58, up 4.64% today as of Sep 10, 12:16 EDT. The company has a market capitalisation of US$9.2M. Over the past 52 weeks, IMNN has traded between US$1.47 and US$5.89. On Syfe you can trade IMNN with $0 commission and add it to your watchlist.
| Previous close | US$1.51 |
|---|---|
| Market cap | US$9.2M |
| 52-week range | US$1.47 – US$5.89 |
| Volume | 22.48K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Imunon, Inc.
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Year: 1995
Imunon Reports Enrollment Above Expectations in Phase 3 Trial of IMNN-001 to Treat Ovarian Cancer
Jul 30, 2:11 PM · MT Newswires
Imunon Says Ovarian Cancer Drug Trial Preliminary Results Show Deeper Antitumor Response
Jul 21, 1:36 PM · MT Newswires
Imunon's Phase 3 Ovarian Cancer Trial Cleared to Continue
Jun 23, 12:48 PM · MT Newswires
Imunon, Inc. (IMNN) stock is trading at US$1.58, +4.64% from the previous close of US$1.51.
The market cap for Imunon, Inc. (IMNN) stock is approximately US$9.2M.
The 52-week high for Imunon, Inc. (IMNN) stock is US$5.89.
The 52-week low for Imunon, Inc. (IMNN) stock is US$1.47.
Imunon, Inc. (IMNN) does not currently pay a dividend.
Stay on top of IMNN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
